Company: BIAF
Filing Date: 2025-04-15
Form Type: DRS
Source: 0001641172-25-004915
Chunk: 5

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-04-15
Form: DRS
Chunk 5
---
Certain information in this prospectus is based on an assumed public offering price of $[____] per share and accompanying April 2025 Warrant (the last reported sale price of our Common Stock on Nasdaq on [____], 2025). The actual public offering price will be determined between us and the Placement Agent based on market conditions at the time of pricing, and may be at a discount to the current market price of our Common Stock. Therefore, the recent market price per share of Common Stock used throughout this prospectus as an assumed combined public offering price may not be indicative of the final offering price.

We are an “emerging growth company” and a “smaller reporting company” as defined under federal securities laws and, as such, have elected to comply with certain reduced public company reporting requirements for this prospectus and may elect to comply with reduced public company reporting requirements in future filings. See “Prospectus Summary––Implications of Being an Emerging Growth Company and a Smaller Reporting Company.”

Investing in our securities involves a high degree of risk. See the section entitled“ Risk Factors” beginning on page 7 of this prospectus for a discussion of risks that should be considered in connection with an investment in our securities.

|                                    |     |   | Per                          
 Share and accompanying April 
 2025 Warrant                 |     |   | Per                    
 Pre-Funded Warrant     
 and accompanying April 
 2025 Warrant           |     |   | Total |
|:-----------------------------------|:----|:--|:-----------------------------|:----|:--|:-----------------------|:----|:--|:------|
| Public offering price              |     | $ |                              |     | $ |                        |     | $ |       |
| Placement Agent fees(1)            |     | $ |                              |     | $ |                        |     | $ |       |
| Proceeds to us, before expenses(2) |     | $ |                              |     | $ |                        |     | $ |       |

| (1) | We                                                                                                                               
 have agreed to pay the Placement Agent a total cash fee equal to 8.0% of the gross proceeds raised in this offering. We have     
 also agreed to reimburse the Placement Agent for its legal fees and expenses and other out-of-pocket expenses in an amount up to 
 $135,000. In addition, we have agreed to issue to the Placement Agent, or its designees, warrants (the “Placement Agent          
 Warrants”)